If this box remains here for more than 30 seconds, click this link to try again.
Products & Services »
Best Practice Database
Medical Affairs » Field Medical Excellence
Download FREE Excerpt
10 Info Graphics
20 Data Graphics
Single User: Authorizes use by the person who places the order or for whom the order was placed.
Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.
Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.
To maximize the impact of oncology-focused field-based medical teams in high-potential global markets, organizations need to be engaging Thought Leaders effectively and efficiently. Complicating an already difficult assignment, field teams must reflect the needs and opportunities of the region they work in.
Best Practices, LLC conducted this study to provide current oncology field team engagement practices in key markets. The study contains benchmarks around the duration and frequency of MSL and HOL interactions; the degree of proactive vs. reactive interactions; and the time spent on internal and external activities
This study will help companies fill knowledge gaps around MSL engagement trends for oncology-focused field medical teams. Leaders involved with field-based medical teams focused on oncology can utilize this study to compare their engagement approaches and metrics with peers in key markets.
This study includes four segments: All Participants, North America, Europe (Germany and UK), and global (countries outside the US).
Twenty field-based medical leaders and medical affairs executives participated in this benchmark research. These leaders provided field performance data and qualitative insights from a total of 15 Oncology pharma and biotech organizations.
Pharmaceutical; Health Care; Biotech; Chemical; Manufacturing; Consumer Products; Diagnostic; Medical Device
AstraZeneca; Daiichi Sankyo; Eisai; EMD Serono; Merck; Genentech; GlaxoSmithKline ; Shire; Janssen; Ipsen; Astellas; Amgen; Bayer; Roche; Merck Serono
If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.